The NBAS Gene Infantile Liver Failure Syndrome Type 2 Genetic Test is a specialized diagnostic procedure designed to detect mutations in the NBAS gene, which are linked to Infantile Liver Failure Syndrome Type 2 (ILFS2). This condition is a rare genetic disorder that affects the liver, often leading to severe liver dysfunction in infancy or early childhood. Symptoms may include jaundice, coagulopathy, and elevated liver enzymes, among others. Early and accurate diagnosis through genetic testing is crucial for managing the condition, allowing for appropriate treatment and interventions to mitigate liver damage and improve the patient's quality of life.
The test is conducted by DNA Labs UAE, a leading facility in genetic diagnostics and research. Utilizing advanced genetic sequencing technologies, the lab offers comprehensive analysis to identify the specific mutations in the NBAS gene responsible for ILFS2. This precise approach aids in confirming the diagnosis, understanding the disease's progression, and potentially guiding genetic counseling for affected families.
The cost of the NBAS Gene Infantile Liver Failure Syndrome Type 2 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the expenses associated with the sophisticated testing procedures and the expertise required to interpret the results accurately. For families facing the challenges of ILFS2, this test represents a critical step towards achieving a clearer understanding of the condition and exploring possible management strategies.
The FAN1 Gene Interstitial Nephritis Karyomegalic Genetic Test is a specialized diagnostic tool designed to identify mutations in the FAN1 gene, which are linked to Karyomegalic Interstitial Nephritis (KIN), a rare genetic disorder. This condition is characterized by chronic kidney disease, where the kidneys show abnormal enlargement of the nuclei in the renal tubular cells, leading to progressive renal failure. Early diagnosis through genetic testing is crucial for managing the disease's progression and exploring potential treatment options.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves analyzing the patient's DNA to detect any genetic abnormalities associated with KIN. Given the complexity and the specialized nature of this test, it is priced at 4400 AED. This test is vital for individuals with a family history of KIN or those showing symptoms related to kidney dysfunction, as it provides a definitive diagnosis, enabling healthcare providers to tailor a management plan that could include monitoring kidney function, managing symptoms, and possibly considering genetic counseling for affected families.
The NR1H4 gene plays a critical role in regulating bile acid transport and metabolism in the liver. Mutations in this gene can lead to conditions such as Intrahepatic Cholestasis of Pregnancy (ICP), a liver disorder that occurs during pregnancy and can result in severe itching and increased risks for the baby, including preterm birth and stillbirth. To identify the genetic basis of ICP and assess the risk for affected individuals and their families, genetic testing targeting the NR1H4 gene is available.
At DNA Labs UAE, a specialized test for the NR1H4 gene related to Intrahepatic Cholestasis of Pregnancy is offered. This test is designed to detect mutations in the NR1H4 gene that are associated with the condition, providing valuable information for managing and treating affected pregnancies. The cost of the test is 4400 AED. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the lab for specific genetic alterations in the NR1H4 gene. Results from this test can help guide clinical decisions, including monitoring and treatment options during pregnancy, to mitigate risks for both the mother and the baby.
The UBR1 Gene Johanson Blizzard Syndrome Genetic Test is a specific diagnostic tool used to identify mutations in the UBR1 gene, which are associated with Johanson-Blizzard Syndrome (JBS). JBS is a rare genetic disorder characterized by a spectrum of symptoms including exocrine pancreatic insufficiency, nasal wing hypoplasia, and various other anomalies affecting the endocrine system, the gastrointestinal tract, and physical development. The test involves analyzing the patient's DNA to detect mutations in the UBR1 gene that are known to cause this syndrome, providing crucial information for accurate diagnosis and management of the condition.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test offers a comprehensive analysis leveraging advanced genomic technologies to ensure high accuracy and reliability. The cost of the UBR1 Gene Johanson Blizzard Syndrome Genetic Test is 4400 AED, reflecting the intricate processes and specialized expertise required to perform this sophisticated analysis. By opting for this test at DNA Labs UAE, patients and their families can expect professional service, detailed results, and support in understanding the implications of the genetic findings for the management of Johanson-Blizzard Syndrome.
The UGT1A1 Gene Hyperbilirubinemia Familial Transient Neonatal Genetic Test is a specialized diagnostic tool aimed at detecting mutations in the UGT1A1 gene, which are known to cause familial transient neonatal hyperbilirubinemia. This condition is characterized by high levels of bilirubin in the blood shortly after birth, leading to jaundice in newborns. It is crucial to identify this genetic predisposition early on to manage and mitigate potential health risks effectively.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, this test provides a comprehensive analysis of the UGT1A1 gene to pinpoint specific mutations. The cost of the test is 4400 AED, reflecting the intricate technology and expertise involved in conducting such specialized genetic testing. By opting for this test, parents can gain valuable insights into their newborn's health, enabling timely and appropriate medical interventions if necessary.
The SLCO1B1 gene hyperbilirubinemia Rotor type genetic test is a sophisticated diagnostic tool designed to detect mutations in the SLCO1B1 gene, which are associated with Rotor syndrome. Rotor syndrome is a rare hereditary condition characterized by chronic, mild, predominantly conjugated hyperbilirubinemia without evidence of hemolysis or overt liver disease. Unlike other forms of genetic hyperbilirubinemia, Rotor syndrome does not lead to significant liver damage but can result in jaundice and bilirubinuria.
The test involves analyzing the patient's DNA to identify specific genetic variations in the SLCO1B1 gene that are linked to the condition. This gene plays a crucial role in the hepatic uptake and processing of bilirubin, and mutations can disrupt these processes, leading to the accumulation of bilirubin in the blood.
Offered by DNA Labs UAE, this genetic test is priced at 4400 AED. The test is conducted in a state-of-the-art laboratory equipped with the latest genetic sequencing technology, ensuring high accuracy and reliability of results. It is a valuable diagnostic tool for individuals experiencing symptoms of hyperbilirubinemia or those with a family history of Rotor syndrome, enabling timely and appropriate management of the condition.
The SLCO1B3 gene hyperbilirubinemia Rotor type genetic test is a specialized diagnostic procedure designed to identify mutations in the SLCO1B3 gene, which are associated with Rotor syndrome. Rotor syndrome is a rare, inherited disorder characterized by chronic, mild, predominantly conjugated hyperbilirubinemia, where bilirubin is not efficiently processed by the liver, leading to its accumulation in the body. Unlike other forms of hyperbilirubinemia, Rotor syndrome does not typically lead to severe liver damage but can result in jaundice and other related symptoms.
This genetic test involves analyzing the patient's DNA to detect specific mutations in the SLCO1B3 gene that are known to cause Rotor syndrome. The process is crucial for the accurate diagnosis of the syndrome, enabling healthcare providers to differentiate it from other conditions that can cause similar symptoms, such as Dubin-Johnson syndrome, thereby guiding appropriate management and treatment strategies.
The test is available at DNA Labs UAE, a leading facility in genetic diagnostics, ensuring high-quality testing services. The cost of the SLCO1B3 gene hyperbilirubinemia Rotor type genetic test at DNA Labs UAE is 4400 AED. Opting for this test at DNA Labs UAE guarantees precise and reliable results, thanks to their state-of-the-art technology and expert team of geneticists and laboratory technicians. Patients seeking to undergo this test can expect professional service and comprehensive support throughout the testing process.
The CDC73 gene hyperparathyroidism type 1 familial genetic test is a specialized diagnostic procedure aimed at identifying mutations in the CDC73 gene, which are known to cause hyperparathyroidism-jaw tumor syndrome (HPT-JT) and familial isolated hyperparathyroidism (FIHP). This test is particularly crucial for individuals with a family history of hyperparathyroidism or related symptoms, as it helps in the early detection and management of the condition. Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test provides a comprehensive analysis of the CDC73 gene to pinpoint any genetic anomalies that may lead to the development of hyperparathyroidism. The cost of the test is 4400 AED, reflecting the advanced technology and expertise involved in conducting this specialized genetic analysis. By opting for this test, patients and their families can gain valuable insights into their genetic health, enabling informed decisions regarding their medical care and the management of potential risks associated with hyperparathyroidism.
The CDC73 gene hyperparathyroidism type 2 familial genetic test is a specialized diagnostic procedure designed to identify mutations in the CDC73 gene, which are associated with the development of familial isolated hyperparathyroidism type 2 (FIHP2). This condition is characterized by the overproduction of parathyroid hormone, leading to elevated calcium levels in the blood and various health issues, including kidney stones, osteoporosis, and severe bone pain.
Conducted at DNA Labs UAE, this genetic test is crucial for individuals with a family history of hyperparathyroidism, as it helps in early detection and management of the condition. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed for specific mutations in the CDC73 gene.
The cost of the CDC73 gene hyperparathyroidism type 2 familial genetic test is 4400 AED. The price reflects the comprehensive analysis and the specialized expertise required to interpret the results accurately. By identifying individuals at risk, this test enables targeted monitoring and timely intervention, potentially preventing the severe complications associated with hyperparathyroidism.
The CASR Gene Hyperparathyroidism Neonatal Severe Genetic Test is a specialized diagnostic procedure aimed at detecting mutations in the CASR gene, which are associated with neonatal severe hyperparathyroidism (NSHPT). NSHPT is a rare, inherited disorder characterized by abnormally high levels of calcium in the blood due to overactivity of the parathyroid glands. This condition can lead to severe complications, including skeletal demineralization and failure to thrive, making early detection and management crucial.
Performed at DNA Labs UAE, this test involves analyzing the patient's DNA to identify any genetic alterations in the CASR gene that may predispose infants to this life-threatening condition. The CASR gene plays a critical role in regulating calcium levels in the body, and mutations in this gene can disrupt this balance, leading to NSHPT.
The cost of the CASR Gene Hyperparathyroidism Neonatal Severe Genetic Test is 4400 AED. Given the complexity and the specialized nature of this test, it represents a vital investment in the health and well-being of affected newborns, allowing for prompt and targeted treatment interventions. This test is an essential tool for parents with a family history of the condition or those whose newborns exhibit symptoms indicative of hyperparathyroidism, ensuring that affected infants receive the necessary care and treatment to mitigate the risks associated with this genetic disorder.
